Ziad Hijazi Selected Research

Ziad Hijazi Research Topics

Disease

64	Atrial Fibrillation 03/2024 - 04/2012
44	Stroke (Strokes) 03/2024 - 04/2012
32	Hemorrhage 01/2023 - 11/2012
18	Embolism (Embolus) 01/2023 - 11/2012
9	Ischemic Stroke 03/2024 - 12/2015
9	Inflammation (Inflammations) 01/2023 - 11/2014
8	Myocardial Infarction 01/2023 - 02/2015
7	Heart Failure 01/2023 - 01/2014
4	Chronic Renal Insufficiency 01/2020 - 11/2012
3	Transient Ischemic Attack 10/2023 - 01/2014
3	Acute Coronary Syndrome 01/2021 - 11/2014
3	Death (Near-Death Experience) 02/2015 - 06/2013
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2020
2	Vascular Calcification 11/2021 - 12/2020
2	Thrombosis (Thrombus) 01/2021 - 01/2020
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2021 - 01/2019
2	Fibrosis (Cirrhosis) 12/2020 - 01/2017
2	Body Weight (Weight, Body) 01/2019 - 01/2016
1	Thromboembolism 10/2023
1	Cerebral Hemorrhage 10/2022
1	Necrosis 01/2022
1	Atherosclerotic Plaque (Atheroma) 01/2021
1	Carcinogenesis 12/2020
1	Ischemia 12/2020
1	Infections 11/2020
1	COVID-19 11/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2020
1	Frailty 01/2019
1	Sudden Death 10/2018
1	Obesity 01/2018
1	Dyslipidemias (Dyslipidemia) 01/2018
1	Clinical Deterioration 01/2016
1	Pulmonary Embolism 12/2015
1	Vascular Diseases (Vascular Disease) 01/2014
1	Diabetes Mellitus 01/2014
1	Hypertension (High Blood Pressure) 01/2014
1	Heart Diseases (Heart Disease) 06/2013

Drug/Important Bio-Agent (IBA)

33	Biomarkers (Surrogate Marker)IBA 03/2024 - 04/2012
30	apixabanIBA 03/2024 - 11/2012
26	Warfarin (Coumadin)FDA LinkGeneric 03/2024 - 11/2012
17	pro-brain natriuretic peptide (1-76)IBA 10/2023 - 04/2012
15	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2023 - 04/2012
11	AnticoagulantsIBA 01/2023 - 11/2012
10	CreatinineIBA 01/2023 - 03/2014
8	Troponin T (Troponin T1)IBA 10/2023 - 01/2014
8	Vitamin K FDA Link 01/2023 - 06/2015
8	Cystatin CIBA 01/2022 - 11/2012
8	Growth Differentiation Factor 15IBA 01/2022 - 11/2014
8	TroponinIBA 01/2020 - 11/2014
6	Troponin IIBA 01/2019 - 04/2012
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 12/2015
5	Dabigatran FDA Link 01/2020 - 03/2014
4	N(4)-oleylcytosine arabinosideIBA 10/2022 - 09/2015
4	Natriuretic PeptidesIBA 11/2021 - 06/2013
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 03/2024 - 11/2021
2	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 03/2024 - 01/2023
2	RivaroxabanIBA 01/2023 - 01/2022
2	Factor Xa (Coagulation Factor Xa)IBA 01/2023 - 01/2022
2	Trefoil Factor-3IBA 01/2022 - 12/2020
2	C-Reactive ProteinIBA 01/2017 - 12/2015
2	trans-crotonin (CTN)IBA 06/2016 - 05/2016
1	Angiopoietin-2IBA 01/2023
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2022
1	CalciumIBA 01/2022
1	CathepsinsIBA 01/2022
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2022
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2022
1	Fibroblast Growth Factor-23IBA 01/2022
1	Urokinase Plasminogen Activator ReceptorsIBA 01/2022
1	darapladibIBA 01/2021
1	sortilinIBA 12/2020
1	Blood Proteins (Serum Proteins)IBA 12/2020
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2020
1	OsteopontinIBA 12/2020
1	Cell Surface ReceptorsIBA 11/2020
1	Angiotensin-Converting Enzyme 2IBA 11/2020
1	DNA (Deoxyribonucleic Acid)IBA 11/2020
1	Thrombin FDA Link 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	antineoplaston A10 (A 10)IBA 01/2020
1	Apolipoproteins B (ApoB)IBA 01/2018
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2018
1	ApolipoproteinsIBA 01/2018
1	Lipoproteins (Lipoprotein)IBA 01/2018
1	Indicators and Reagents (Reagents)IBA 08/2017
1	fibrin fragment D (D-dimer)IBA 01/2017
1	CytokinesIBA 01/2017
1	Trinitrotoluene (TNT)IBA 01/2014

Therapy/Procedure

21	Therapeutics 01/2023 - 04/2012
2	Percutaneous Coronary Intervention 01/2021 - 01/2019
2	Stents 01/2021 - 01/2020
1	Catheter Ablation 12/2023
1	Polypharmacy 01/2019
1	Drug Tapering 01/2016